WAYFINDER THERAPEUTICS
Live / Applied — Suspended — suspension check completed, case still suspended (as of 27 May 2025)
What this means for you
Not registered yet, but its 28 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98425071
- Mark type
- Stylized text
- Filed
- 28 Feb 2024
- Attorney of record
- Brian D. Gildea
Goods and services
- Class 005 — Pharmaceuticals: Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities
- Class 042 — Scientific and technological services: Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system fields
Owner
- Gildea, Brian D, Ormond Beach, FL, US
Prosecution history
- 16 Dec 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 15 Dec 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 27 May 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 25 Nov 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 25 Nov 2024 — LETTER OF SUSPENSION E-MAILED
- 25 Nov 2024 — SUSPENSION LETTER WRITTEN
- 22 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Nov 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Sept 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Sept 2024 — NON-FINAL ACTION E-MAILED
- 18 Sept 2024 — NON-FINAL ACTION WRITTEN
- 16 Sept 2024 — ASSIGNED TO EXAMINER
- 09 Jul 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Feb 2024 — NEW APPLICATION ENTERED